Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Hanlin Zhang for being awarded the first Oxford-Elysium Fellowship in cellular health.

This three year fellowship is aimed at supporting the brightest and most promising scientists in their early research careers at the University of Oxford.

The award will support his study into autophagy; the intracellular degradation system which recycles damaged cellular components. Decreased autophagy levels have been associated with age-related diseases such as neurodegeneration and cancer. Hanlin aims to elucidate a novel autophagy signaling pathway and identify novel drug targets within this pathway to increase autophagy levels to achieve healthier ageing.

Commenting on his award, Hanlin said "Human ageing is a very complex process and associated with many severe diseases. Autophagy plays a critical role in regulating cell homeostasis and senescence. I am happy and grateful to be awarded this early-career fellowship. It will help me gain a deeper insight into this novel autophagy and ageing pathway, which might help unveil the ageing mystery.”

Hanlin will be based primarily within the Kennedy Institue under the supervision of Prof. Katja Simon.

Funding Body

elysium-logo.jpg

Similar stories

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters "good" macrophage behaviour within the vessel wall.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.

Large genetic study suggests shared biological processes cause irritable bowel syndrome and anxiety

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.